Skip to main content
MedPathMedPath Home
Clinical Trials/NCT01138982
NCT01138982
Completed
Not Applicable

A Randomized Effectiveness Trial of a One-to-one, Adult-to-youth Mentoring Program in Sweden

Karolinska Institutet1 site in 1 country128 target enrollmentOctober 2007
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsSubstance Use

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Substance Use
Sponsor
Karolinska Institutet
Enrollment
128
Locations
1
Primary Endpoint
Self-reported substance use
Status
Completed
Last Updated
10 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSitesSimilar Trials

Overview

Brief Summary

This study aims to investigate the effectiveness of a one-to-one, adult-to-youth primary preventive mentoring program in Sweden. Outcome domains and criteria for inclusion and exclusion of study participants are elaborated in collaboration with the providing NGO, and the program is given as customary.

Registry
clinicaltrials.gov
Start Date
October 2007
End Date
June 2009
Last Updated
10 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Maria Bodin

PhD

Karolinska Institutet

Eligibility Criteria

Inclusion Criteria

  • •a self-reported need of the youth for additional adult contacts

Exclusion Criteria

  • •current or past regular use of illicit drugs
  • •repeated delinquent behaviour or single acts of violence against persons
  • •ongoing contacts with psychiatric care or social services

Outcomes

Primary Outcomes

Self-reported substance use

Time Frame: One year

Self-reported substance use among youth

Secondary Outcomes

  • Youth delinquency(One year)

Study Sites (1)

Loading locations...

Similar Trials

Completed
Phase 2
An Exploratory Study to Evaluate the Prophylactic Efficacy of a Single Immunization of Ad26.RSV.preF Against Respiratory Syncytial Virus Infection in a Virus Challenge Model in Healthy 18 to 50 Year-old AdultsHealthy
NCT03334695Janssen Vaccines & Prevention B.V.64
Completed
Phase 2
Once-A-Day Prophylaxis for Youth and Young Adults With Severe Hemophilia AHemophilia A
NCT00717626The Hospital for Sick Children14
Recruiting
Phase 1
A Phase 1 With Extension Cohort, Single Arm, Single Center, Open Label Trial of Belantamab Mafodotin for the Treatment of High-Risk Smoldering Multiple MyelomaMyeloma
NCT05055063M.D. Anderson Cancer Center30
Completed
Phase 1
Efficacy of VIC Regimen in BRAF Mutant Metastatic Colorectal CancerColorectal Cancer Metastatic
NCT04790448Sun Yat-sen University37
Recruiting
Phase 1
A Study to Investigate the Safety, Tolerability, and Efficacy of BxC-I17e Single and Multiple Dose SC Injection in Patients With Moderate to Severe Atopic DermatitisAtopic Dermatitis
NCT06055361Brexogen Inc.45